The United States’ most influential courts have made 2005 a vintage year for decisions affecting the life science and pharmaceutical sectors. As the year draws to a close, the time is ripe to review the most significant decisions and evaluate the current state and trends of the living, ever-changing patent jurisprudence.

The court decisions that garnered a spot among McDermott’s 2005 Life Science Top 10 will broadly impact the practices of patent litigators and prosecutors alike and address topics including, the Hatch-Waxman Act, claim construction and the constantly evolving application of various patentability requirements. From claim drafting to litigating validity and enforceability, the patent law decisions of 2005 hold important lessons for patent holders and anyone charged with procuring and defending patent rights. The subject matter addressed in the top three decisions illustrates this point....

This service is completely FREE but for the full article and thousands of other articles from 100+ countries please tell us about yourself by registering (and yes, our lawyers like to think you've read our Disclaimer). It only takes 30 seconds and as well as great content you get articles more relevant to you and other advanced features like an optional personalised once-weekly news alert and forward-to-colleague capabilities. We'll also remember your details so you don't have to login again - if you've registered before please login here or if you've forgotten your username click here and we'll remind you. We appreciate your time is important and will respect your privacy - THANK YOU for registering.

Specific Questions relating to this article should be addressed directly to the author.

Do you have a question for the author?